# Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy

> **NCT05519397** · — · COMPLETED · sponsor: **Istanbul Training and Research Hospital** · enrollment: 56 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Immune checkpoint measurement

## Key facts

- **NCT ID:** NCT05519397
- **Lead sponsor:** Istanbul Training and Research Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-09-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2023-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05519397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05519397, "Evaluation of the Role of Immune Checkpoints in Response to Breast Cancer Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT05519397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*